My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 380

    1.

    The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.

    Mast ST, Jollis JG, Ryan T, Anstrom KJ, Crary JL.

    Ann Intern Med. 2001 Feb 20;134(4):261-6.PMID: 11182835 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.

    Gardin JM, Schumacher D, Constantine G, Davis KD, Leung C, Reid CL.

    JAMA. 2000 Apr 5;283(13):1703-9.PMID: 10755496 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.

    Gardin JM, Weissman NJ, Leung C, Panza JA, Fernicola D, Davis KD, Constantine GD, Reid CL.

    JAMA. 2001 Oct 24-31;286(16):2011-4.PMID: 11667938 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.

    Ryan DH, Bray GA, Helmcke F, Sander G, Volaufova J, Greenway F, Subramaniam P, Glancy DL.

    Obes Res. 1999 Jul;7(4):313-22.PMID: 10440587 [PubMed - indexed for MEDLINE]Related articles

    5.

    Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine.

    Kancherla MK, Salti HI, Mulderink TA, Parker M, Bonow RO, Mehlman DJ.

    Am J Cardiol. 1999 Dec 1;84(11):1335-8.PMID: 10614800 [PubMed - indexed for MEDLINE]Related articles

    6.

    Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication.

    Wee CC, Phillips RS, Aurigemma G, Erban S, Kriegel G, Riley M, Douglas PS.

    Ann Intern Med. 1998 Dec 1;129(11):870-4. Erratum in: Ann Intern Med 2000 Jan 18;132(2):167. PMID: 9867728 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.

    Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT.

    N Engl J Med. 1998 Sep 10;339(11):725-32.PMID: 9731088 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trial.

    Weissman NJ, Panza JA, Tighe JF, Gwynne JT.

    Ann Intern Med. 2001 Feb 20;134(4):267-73.PMID: 11182836 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.

    Khan MA, Herzog CA, St Peter JV, Hartley GG, Madlon-Kay R, Dick CD, Asinger RW, Vessey JT.

    N Engl J Med. 1998 Sep 10;339(11):713-8.PMID: 9731086 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatment.

    Weissman NJ, Tighe JF Jr, Gottdiener JS, Gwynne JT.

    J Am Coll Cardiol. 1999 Dec;34(7):2088-95.PMID: 10588229 [PubMed - indexed for MEDLINE]Related articles

    11.

    Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation.

    Mast ST, Gersing KR, Anstrom KJ, Krishnan KR, Califf RM, Jollis JG.

    Am J Cardiol. 2001 Apr 15;87(8):989-93: A4.PMID: 11305992 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies.

    Sachdev M, Miller WC, Ryan T, Jollis JG.

    Am Heart J. 2002 Dec;144(6):1065-73. Review.PMID: 12486432 [PubMed - indexed for MEDLINE]Related articles

    13.

    Low risk of significant echocardiographic valvulopathy in patients treated with anorectic drugs.

    Burger AJ, Charlamb MJ, Singh S, Notarianni M, Blackburn GL, Sherman HB.

    Int J Cardiol. 2001 Jul;79(2-3):159-65.PMID: 11461737 [PubMed - indexed for MEDLINE]Related articles

    14.

    A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.

    Jick H, Vasilakis C, Weinrauch LA, Meier CR, Jick SS, Derby LE.

    N Engl J Med. 1998 Sep 10;339(11):719-24.PMID: 9731087 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study.

    Palmieri V, Arnett DK, Roman MJ, Liu JE, Bella JN, Oberman A, Kitzman DW, Hopkins PN, Morgan D, de Simone G, Devereux RB.

    Am J Med. 2002 Jun 15;112(9):710-5.PMID: 12079711 [PubMed - indexed for MEDLINE]Related articles

    16.

    Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.

    Teramae CY, Connolly HM, Grogan M, Miller FA Jr.

    Mayo Clin Proc. 2000 May;75(5):456-61.PMID: 10807073 [PubMed - indexed for MEDLINE]Related articles

    17.

    Operation for anorexigen-associated valvular heart disease.

    Caccitolo JA, Connolly HM, Rubenson DS, Orszulak TA, Schaff HV.

    J Thorac Cardiovasc Surg. 2001 Oct;122(4):656-64.PMID: 11581595 [PubMed - indexed for MEDLINE]Related articles

    18.

    Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities.

    Jollis JG, Landolfo CK, Kisslo J, Constantine GD, Davis KD, Ryan T.

    Circulation. 2000 May 2;101(17):2071-7.PMID: 10790349 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prevalence and severity of Doppler-detected valvular regurgitation and estimation of right-sided cardiac pressures in patients with normal two-dimensional echocardiograms.

    Lavie CJ, Hebert K, Cassidy M.

    Chest. 1993 Jan;103(1):226-31.PMID: 8417884 [PubMed - indexed for MEDLINE]Related articles

    20.

    Valvular heart disease associated with fenfluramine-phentermine.

    Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV.

    N Engl J Med. 1997 Aug 28;337(9):581-8. Erratum in: N Engl J Med 1997 Dec 11;337(24):1783. PMID: 9271479 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity